Observational studyBMC cancer2019

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study.

Kerri Beckmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.